pemafibrate
Kowa Pharmaceuticals
[]
 discusses prominent #aha22 - in the statin era,no cv benefit with fibrates( with ldl controlled- in prominent trial median was 78) 
AssistProfessor #cardiologist #SoMe #editor @CircOutcomes & @JournalASEcho #BOD @ase360 #ACCWIC @PittHealthSci #MedHumanities @ColumbiaMed @NUFeinbergMed